Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities - Schedule of Warrants to Purchase Common Stock (Details)

v3.22.2.2
Derivative Liabilities - Schedule of Warrants to Purchase Common Stock (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Warrants outstanding $ 7,309,000 $ 4,776,000
Exercise Price $3.120    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Warrants outstanding $ 496,415  
Conversion price (in dollars per share) $ 3.120  
Exercise Price $3.430    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Warrants outstanding $ 510,204  
Conversion price (in dollars per share) $ 3.430  
Exercise Price $4.125    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Warrants outstanding $ 424,242  
Conversion price (in dollars per share) $ 4.125  
Exercise Price $6.875    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Warrants outstanding $ 127,273  
Conversion price (in dollars per share) $ 6.875